Julian Chang

Array ( [id] => 6423545 [patent_doc_number] => 20100167997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'METHOD FOR STIMULATION COLLAGEN SYNTHESIS AND/OR KGF EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/815307 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8841 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167997.pdf [firstpage_image] =>[orig_patent_app_number] => 11815307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368414 [patent_doc_number] => 20090305973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'NOVEL PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/161938 [patent_app_country] => US [patent_app_date] => 2006-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6296 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305973.pdf [firstpage_image] =>[orig_patent_app_number] => 12161938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898928 [patent_doc_number] => 20080118542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Growth Factor Composition' [patent_app_type] => utility [patent_app_number] => 11/795234 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5689 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118542.pdf [firstpage_image] =>[orig_patent_app_number] => 11795234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 816971 [patent_doc_number] => 07410779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-12 [patent_title] => 'Fusion polypeptides of human serum albumin and a therapeutically active polypeptide' [patent_app_type] => utility [patent_app_number] => 11/330353 [patent_app_country] => US [patent_app_date] => 2006-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 12614 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/410/07410779.pdf [firstpage_image] =>[orig_patent_app_number] => 11330353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724316 [patent_doc_number] => 08097586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Modified exedins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/813917 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8773 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097586.pdf [firstpage_image] =>[orig_patent_app_number] => 11813917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874351 [patent_doc_number] => 20060166328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'IGF-I fusion polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/327555 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9944 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166328.pdf [firstpage_image] =>[orig_patent_app_number] => 11327555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199688 [patent_doc_number] => 20070299006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Recombinant fusion proteins to growth hormone and serum albumin' [patent_app_type] => utility [patent_app_number] => 11/315035 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6782 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299006.pdf [firstpage_image] =>[orig_patent_app_number] => 11315035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649001 [patent_doc_number] => 20060134736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Human growth hormone conjugated with biocompatible polymer' [patent_app_type] => utility [patent_app_number] => 11/314926 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8154 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134736.pdf [firstpage_image] =>[orig_patent_app_number] => 11314926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747847 [patent_doc_number] => 20060110778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'High-throughput screen for identifying selective persistent sodium channels channel blockers' [patent_app_type] => utility [patent_app_number] => 11/313450 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21845 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110778.pdf [firstpage_image] =>[orig_patent_app_number] => 11313450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485732 [patent_doc_number] => 20090275497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'METHOD FOR IDENTIFYING MODULATORS OF THE ACTIVITY OF ION-CHANNELS RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/721630 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5233 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275497.pdf [firstpage_image] =>[orig_patent_app_number] => 11721630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5649015 [patent_doc_number] => 20060134750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Method of treatment using interferon-tau' [patent_app_type] => utility [patent_app_number] => 11/298972 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134750.pdf [firstpage_image] =>[orig_patent_app_number] => 11298972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715579 [patent_doc_number] => 20060078942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Method of treatment using interferon-tau' [patent_app_type] => utility [patent_app_number] => 11/298955 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16442 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078942.pdf [firstpage_image] =>[orig_patent_app_number] => 11298955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32708 [patent_doc_number] => 07790693 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Glucose-transport related genes, polypeptides, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/292549 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 17848 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790693.pdf [firstpage_image] =>[orig_patent_app_number] => 11292549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272128 [patent_doc_number] => 20090075904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Protein Hydrolysate Enriched In Peptides Inhibiting DPP-IV And Their Use' [patent_app_type] => utility [patent_app_number] => 11/722667 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6690 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075904.pdf [firstpage_image] =>[orig_patent_app_number] => 11722667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5613547 [patent_doc_number] => 20060115475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Toll like receptor 3 antagonists, methods and uses' [patent_app_type] => utility [patent_app_number] => 11/291140 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 19917 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20060115475.pdf [firstpage_image] =>[orig_patent_app_number] => 11291140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748363 [patent_doc_number] => 20060111295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Cellular receptors utilized as carrier agents for pharmaceutical compounds used in the treatment of arthritis, inflammation and immune disorders' [patent_app_type] => utility [patent_app_number] => 11/284573 [patent_app_country] => US [patent_app_date] => 2005-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2493 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111295.pdf [firstpage_image] =>[orig_patent_app_number] => 11284573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959708 [patent_doc_number] => 20080274133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Soluble Bifunctional Proteins' [patent_app_type] => utility [patent_app_number] => 11/667276 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 12584 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274133.pdf [firstpage_image] =>[orig_patent_app_number] => 11667276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5198723 [patent_doc_number] => 20070298041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Ligands That Enhance Endogenous Compounds' [patent_app_type] => utility [patent_app_number] => 11/667393 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 54396 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298041.pdf [firstpage_image] =>[orig_patent_app_number] => 11667393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5648389 [patent_doc_number] => 20060134121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'DII4 antagonists, assays, and therapeutic methods thereof' [patent_app_type] => utility [patent_app_number] => 11/264243 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9356 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134121.pdf [firstpage_image] =>[orig_patent_app_number] => 11264243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834140 [patent_doc_number] => 20080132687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Pharmaceutical Preparation For The Treatment Of Friedreich\'s Ataxia' [patent_app_type] => utility [patent_app_number] => 11/718870 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3432 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132687.pdf [firstpage_image] =>[orig_patent_app_number] => 11718870 [rel_patent_id] =>[rel_patent_doc_number] =>)